Risk stratification for prostate cancer management: value of the Cambridge Prognostic Group classification for assessing treatment allocation
暂无分享,去创建一个
N. Clarke | H. Payne | V. Gnanapragasam | B. Berry | M. Parry | A. Sujenthiran | J. Nossiter | T. Cowling | A. Aggarwal | P. Cathcart | J. H. van der Meulen | J. Meulen | P. Cathcart | N. Clarke